Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.79 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.79 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.79 |
| ▸ | APAF1 | O14727 | 1/20 | 0.79 |
| ▸ | NPC1 | O15118 | 1/20 | 0.79 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.79 |
| ▸ | MAPT | P10636 | 1/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.79 |
| ▸ | HTT | P42858 | 1/20 | 0.79 |
| ▸ | RAB9A | P51151 | 1/20 | 0.79 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.79 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.79 |
| ▸ | FDPS | P14324 | 16/20 | 0.41 |
| ▸ | PON1 | P27169 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL17273624 | 0.98 | MEN1 (0.76) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL34969 | 0.98 | MEN1 (0.81) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Iodide SCHEMBL4557376 | 0.96 | MEN1 (0.73) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL2580666 | 0.96 | MEN1 (0.79) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Fluoride Ion SCHEMBL1898684 | 0.96 | MEN1 (0.79) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL358571 | 0.96 | MEN1 (0.79) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Iodide SCHEMBL3697966 | 0.96 | MEN1 (0.79) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Bromide SCHEMBL232599 | 0.96 | SMN1; SMN2 (0.85) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Hydrochloric Acid SCHEMBL20957483 | 0.96 | MEN1 (0.79) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Hydrochloric Acid SCHEMBL36719 | 0.96 | MEN1 (0.79) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 982 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078235-A1 | METHOD FOR POLYURETHANE DEPOLYMERIZATION | UNIV MURCIA (ES) | 2026-03-19 | — | — | US | claimed |
| US-20250188048-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | JIANGSU CELLURANICS NEW MATERIAL TECHNOLOGY CO., LTD. (CN) | 2025-06-12 | — | — | US | claimed |
| EP-4556514-A1 | METHOD FOR POLYURETHANE DEPOLYMERIZATION | Universidad de Murcia (ES) | 2025-05-21 | — | — | EP | claimed |
| CN-115938814-B | Morphology-reconfigurable structural supercapacitor and preparation method thereof | 吉林大学 | 2025-02-07 | — | — | CN | claimed |
| US-12180380-B2 | Highly conductive, printable ink for highly stretchable soft electronics and highly conductive, ultra-stretchable conductors obtainable therefrom | Karlsruher Institut für Technologie (DE) | 2024-12-31 | — | — | US | claimed |
| EP-4477651-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | Jiangsu Celluranics New Material Technology Co., Ltd. (CN) | 2024-12-18 | — | — | EP | claimed |
| US-12157287-B2 | Variable emissivity surfaces | THE UNIVERSITY OF MANCHESTER (GB) | 2024-12-03 | — | — | US | claimed |
| CN-115775887-B | Structure-designable structure battery and preparation method thereof | 吉林大学 | 2024-08-23 | — | — | CN | claimed |
| EP-4408827-A1 | A NEW INTERMEDIATE FOR PREPARATION OF OXAZOLE COMPOUNDS | DSM IP Assets B.V. (NL) | 2024-08-07 | — | — | EP | claimed |
| EP-4408828-A1 | A PROCESS FOR PREPARATION OF OXAZOLE COMPOUNDS | DSM IP Assets B.V. (NL) | 2024-08-07 | — | — | EP | claimed |
| WO-2006122563-A1 | A PROCESS FOR CONTINUOUS CARBONYLATION BY SUPPORTED IONIC LIQUID-PHASE CATALYSIS | DANMARKS TEKNISKE UNIVERSITET (DK) | 2006-11-23 | — | — | WO | claimed |
| US-6916951-B2 | Continuous carbonylation process | EASTMAN CHEMICAL COMPANY (US) | 2005-07-12 | — | — | US | claimed |
| EP-1501779-A1 | CONTINUOUS CARBONYLATION PROCESS | EASTMAN CHEMICAL COMPANY (US) | 2005-02-02 | — | — | EP | claimed |
| WO-2003093211-A1 | CONTINUOUS CARBONYLATION PROCESS | EASTMAN CHEMICAL COMPANY (US) | 2003-11-13 | — | — | WO | claimed |
| US-20030212295-A1 | Continuous carbonylation process | EASTMAN CHEMICAL COMPANY | 2003-11-13 | — | — | US | claimed |
| US-6579343-B2 | Contacting gas with a liquid ionic compound comprising a nitrogen-containing heterocyclic cation | UNIVERSITY OF NOTRE DAME DU LAC | 2003-06-17 | — | — | US | claimed |
| US-20020189444-A1 | Purification of gas with liquid ionic compounds | NATIONAL SCIENCE FOUNDATION | 2002-12-19 | — | — | US | claimed |
| US-6384321-B1 | THAT FORMS AN ONIUM SALT WITH A IMIDAZOLIUM SALT; A HALOGEN CONTAINING COMPOUND; NITROGEN, PHOSPHOROUS OR SULFUR CONTAINING COMPOUND | KABUSHIKI KAISHA TOSHIBA (JP) | 2002-05-07 | — | — | US | claimed |
| EP-1087412-A2 | Electrolyte composition, photosensitized solar cell using said electrolyte composition, and method of manufacturing photosensitized solar cell | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-03-28 | — | — | EP | claimed |
| US-6048388-A | Ink compositions containing ionic liquid solvents | XEROX CORPORATION | 2000-04-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250188048-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | HPD, DPYD, PGD | MEN1 4667/4885HSP90AA1 3762/4885KMT2A 3074/4885 |
| US-20030212295-A1 | Continuous carbonylation process | CA4, CA5B, CA14 | MEN1 2843/4885HSP90AA1 2383/4885KMT2A 1452/4885 |
| US-20260078235-A1 | METHOD FOR POLYURETHANE DEPOLYMERIZATION | FGB, POLR2B, POLB | MEN1 3542/4885HSP90AA1 1655/4885KMT2A 1909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.